Bacher M, Meinhardt A, Lan H Y, Dhabhar F S, Mu W, Metz C N, Chesney J A, Gemsa D, Donnelly T, Atkins R C, Bucala R
Picower Institute for Medical Research, Manhasset, New York, USA.
Mol Med. 1998 Apr;4(4):217-30.
The mediator known historically as macrophage migration inhibitory factor (MIF) has been identified recently as being released into the circulation by the anterior pituitary gland as a consequence of stress or during a systemic inflammatory response. Macrophages and T cells also secrete MIF, both in response to proinflammatory factors or upon stimulation with glucocorticoids. Once released, MIF "overrides" or counterregulates the immunosuppressive effects of steroids on cytokine production and immune cellular activation. To further investigate the biology of MIF and its role in the neuroendocrine system, we have studied the regional and cellular expression of MIF in brain tissue obtained from normal rats and rats administered LPS intracisternally.
Rat brain sections were analyzed by immunohistochemistry utilizing an affinity-purified, anti-MIF antibody raised to recombinant MIF, and by in situ hybridization using a digoxigenin-labeled, antisense MIF cRNA probe. The kinetics of MIF mRNA expression in brain were compared with that of IL-1, IL-6, and TNF-alpha by RT-PCR of total brain RNA. The cerebrospinal fluid content of MIF and TNF-alpha proteins was analyzed by Western blotting and ELISA.
A strong baseline expression pattern for MIF was observed in neurons of the cortex, hypothalamus, hippocampus, cerebellum, and pons. By in situ hybridization, MIF mRNA was found predominantly in cell bodies whereas MIF protein was detected mostly within the terminal fields associated with neurons. There was a marked pattern of MIF immunoreactivity within the mossy fibers of the dentate gyrus and dendrites of the hippocampal CA3 field. These structures have been shown previously to be involved in glucocorticoid-induced tissue damage within the hippocampus, suggesting an association between MIF and targets of glucocorticoid action. The intracisternal injection of LPS increased MIF mRNA and protein expression in brain and MIF immunoreactivity was due in part to infiltrating monocytes/macrophages. MIF protein also was found to be rapidly released into the cerebrospinal fluid. This response corresponded with that of LPS-induced cytokine release and MIF mRNA expression increased in a distribution that colocalized in large part with that of TNF-alpha, IL-1 beta, and IL-6.
The significant levels of baseline and inducible MIF expression in the brain and its regional association with glucocorticoid action underscore the importance of this mediator as a physiological regulator of the inflammatory stress response and further define its role within the neuroendocrine system.
历史上被称为巨噬细胞移动抑制因子(MIF)的介质最近被确定为由垂体前叶在应激状态下或全身炎症反应期间释放到循环系统中。巨噬细胞和T细胞也会响应促炎因子或在受到糖皮质激素刺激时分泌MIF。一旦释放,MIF就会“抵消”或反调节类固醇对细胞因子产生和免疫细胞激活的免疫抑制作用。为了进一步研究MIF的生物学特性及其在神经内分泌系统中的作用,我们研究了从正常大鼠和脑池内注射脂多糖(LPS)的大鼠获取的脑组织中MIF的区域和细胞表达情况。
利用针对重组MIF产生的亲和纯化抗MIF抗体,通过免疫组织化学分析大鼠脑切片,并使用地高辛标记的反义MIF cRNA探针进行原位杂交。通过对全脑RNA进行逆转录聚合酶链反应(RT-PCR),将脑中MIF mRNA表达的动力学与白细胞介素-1(IL-1)、白细胞介素-6(IL-6)和肿瘤坏死因子-α(TNF-α)的动力学进行比较。通过蛋白质印迹法和酶联免疫吸附测定(ELISA)分析脑脊液中MIF和TNF-α蛋白的含量。
在皮质、下丘脑、海马、小脑和脑桥的神经元中观察到MIF的强基线表达模式。通过原位杂交发现,MIF mRNA主要存在于细胞体中,而MIF蛋白大多在与神经元相关的终末区域检测到。在齿状回的苔藓纤维和海马CA3区的树突内有明显的MIF免疫反应模式。这些结构先前已被证明与糖皮质激素诱导的海马组织损伤有关,提示MIF与糖皮质激素作用靶点之间存在关联。脑池内注射LPS可增加脑中MIF mRNA和蛋白表达,且MIF免疫反应性部分归因于浸润的单核细胞/巨噬细胞。还发现MIF蛋白迅速释放到脑脊液中。这种反应与LPS诱导的细胞因子释放相对应,且MIF mRNA表达增加的分布在很大程度上与TNF-α、IL-1β和IL-6的分布共定位。
脑中MIF的基线和诱导表达水平显著,且其区域与糖皮质激素作用相关,这突出了该介质作为炎症应激反应生理调节因子的重要性,并进一步明确了其在神经内分泌系统中的作用。